Complete your online assessment
Start with a short questionnaire about your health history and your goals. You can complete it from any device in Rhode Island, at whatever hour suits you, with no office to travel to.
Provider guided GLP-1 care
Personalized Compounded Tirzepatide in Rhode Island.
An online path to personalized compounded tirzepatide for people in Rhode Island. You answer a health questionnaire, a licensed provider reviews it, and if treatment is appropriate your prescription is filled by a pharmacy partner and delivered to you.
✓ LegitScript certified✓ Licensed providers✓ One price, every dose
How it works
Getting started in Rhode Island
Three steps, all online, from the first question to the delivery at your door.
A licensed provider reviews it
Clinical services for applicable Bodi Envi programs are provided by Wasef Health, PC. A licensed provider decides whether personalized compounded tirzepatide is appropriate for you.
Your prescription ships to you
A prescription, if one is issued, is dispensed by VialsRx, Bodi Envi's pharmacy partner for GLP-1 prescriptions, and delivered to your Rhode Island address.
Please note: a licensed provider determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued.
Understanding personalized compounded tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Where semaglutide works on one receptor, tirzepatide engages two, each tied to a hormone involved in fullness and blood sugar control. For Rhode Island residents, it is the medication behind Bodi Envi's Personalized Compounded Tirzepatide Weight-Management Programs.
In a compounded program, a licensed compounding pharmacy prepares the medication for a specific patient after a licensed provider has written the prescription. The provider sets the weekly injection schedule, picks the starting dose and decides whether and when it changes.
It is important to be clear about what compounded means. Personalized Compounded Tirzepatide has not been approved by the FDA and is not the same as Mounjaro® and Zepbound®, the FDA-approved products. Compounded drugs are not reviewed by the FDA for safety, effectiveness or quality before they are marketed. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Pricing
Personalized Compounded Tirzepatide pricing for Rhode Island residents
There is one price list, and it applies in Rhode Island exactly as it does everywhere else. Pick the term that suits you, from monthly to twelve months, knowing that a dose adjustment from your provider will not raise the price.
Monthly
$229/ month
Billed monthly
3 months
$219/ month
$657 paid once
6 months
$205/ month
$1,230 paid once
12 months
$175/ month
$2,100 paid once
For applicable programs, pricing does not increase based solely on dosage strength. Medication is included only when a licensed healthcare provider determines treatment is medically appropriate and issues a prescription. Current pricing and plan details are on the Plans page.
What is included
- Online health assessment and review by a licensed provider
- Personalized Compounded Tirzepatide when a provider determines it is appropriate
- Ongoing care team messaging and treatment monitoring
- Dispensing and delivery by a licensed pharmacy partner
- One price regardless of dose strength
Available across Rhode Island
Because nothing depends on a physical location, Rhode Island is served as a whole. Residents of Providence, Cranston, Warwick, Pawtucket, East Providence and Woonsocket and of the towns between them complete the same online assessment and, if personalized compounded tirzepatide is prescribed, receive it at a valid address anywhere in the state.
How pharmacies serving Rhode Island are regulated
The Rhode Island Board of Pharmacy is the Rhode Island agency responsible for licensing and inspecting pharmacies that serve patients in the state. When personalized compounded tirzepatide is prescribed, a licensed compounding pharmacy prepares it for that patient specifically. Bodi Envi is not a pharmacy, not a medical practice and not a manufacturer, and it does not compound medications. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards. Rhode Island Board of Pharmacy.
Read more
No clinic visit, wherever you are in Rhode Island
Bodi Envi is a telehealth platform, so the whole process happens where you already are. Someone in Warwick and someone in Pawtucket complete the same assessment from home, are reviewed by the same licensed providers, and message the care team through the same secure channel. If personalized compounded tirzepatide is prescribed, it is delivered to a home address in Rhode Island rather than collected from a clinic. Distance from a city stop being a factor in whether Rhode Island residents can be seen.
Questions
Personalized Compounded Tirzepatide in Rhode Island
Straight answers about eligibility, pricing and how the program works where you live.
Yes, through telehealth. Eligible adults in Rhode Island are evaluated online by licensed providers, and where personalized compounded tirzepatide is prescribed the pharmacy partner dispenses it and ships it to your Rhode Island address. Compounded medications are not FDA-approved and treatment is never guaranteed.
Rhode Island patients pay the published national price: $229 a month on monthly billing, dropping to $219 on the 3-month term, $205 on the 6-month term and $175 a month on the 12-month term. Pricing does not increase based solely on dosage strength, and the /pricing page is the place to check the latest numbers.
You do not. The whole evaluation is online: an assessment you complete from home, reviewed by a licensed provider with Wasef Health, PC, who decides whether personalized compounded tirzepatide is appropriate. In most states the tailored treatment plan comes to you through online questionnaire and secure chat.
Licensed healthcare providers independently evaluate each Rhode Island patient and decide whether treatment is medically appropriate. Wasef Health, PC is the clinical provider organization for applicable Bodi Envi programs, with Michael Wasef, MD as Medical Director.
VialsRx is Bodi Envi's current pharmacy partner for GLP-1 prescriptions, including those written for Rhode Island patients. Pharmacy partners dispense and fulfill prescriptions when a licensed provider prescribes, and ship to your Rhode Island address. Pharmacy availability may vary by program and patient location.
No. Personalized Compounded Tirzepatide is not FDA-approved and is not equivalent to FDA-approved products such as Mounjaro® and Zepbound®. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Yes. Bodi Envi is a LegitScript-certified telehealth platform. You can confirm the certification on LegitScript's own site through the badge in the footer of every page.
It does. Eligible adults in Rhode Island can be considered for personalized compounded semaglutide as well as personalized compounded tirzepatide, and a licensed provider with Wasef Health, PC advises which, if either, suits your health history. Micro-dose versions of both are also offered.
A micro-dose program for tirzepatide exists and is open to eligible adults in Rhode Island. You do not choose the dose yourself: after the assessment, a licensed provider with Wasef Health, PC determines the dosing approach that is appropriate, if any.
Your assessment goes to a licensed provider with Wasef Health, PC, who evaluates it and decides whether to prescribe. When a prescription is issued, VialsRx dispenses the medication and delivers it to your Rhode Island address. From there you can message the care team about your treatment at any point.
Important information about compounded medications
Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.
The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.
Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.
Ready when you are
Start your personalized compounded tirzepatide assessment in Rhode Island
Complete the online assessment in a few minutes. A licensed provider reviews it, and if personalized compounded tirzepatide is right for you, your plan ships to your Rhode Island address. Treatment is not guaranteed, and the price you see is the price Rhode Island residents pay. If a patient is not qualified, a refund will be issued.